Q32 Bio Inc. (QTTB) Non-Current Assets (2017 - 2026)

Q32 Bio has reported Non-Current Assets for 10 years, with the latest figure at $6.2 million in Q2 2026.

• On a quarterly basis, Non-Current Assets fell 20.17% year-over-year to $6.2 million in Q2 2026; TTM through Jun 2026 was $26.4 million, a 32.89% decrease from a year earlier, with the FY2025 full-year figure at $6.7 million, down 35.67% from the prior year.
• Non-Current Assets was $6.2 million for Q2 2026 at Q32 Bio, down from $6.5 million in the prior quarter.
• The five-year high for Non-Current Assets was $228.7 million in Q4 2022, with the low at $6.2 million in Q2 2026.
• Average Non-Current Assets over 5 years is $36.4 million, with a median of $13.4 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Non-Current Assets surged 1054.58% in 2022, then slumped 85.96% in 2024.
• Over 5 years, Non-Current Assets stood at $228.7 million in 2022, then tumbled by 67.45% to $74.5 million in 2023, then plunged by 85.96% to $10.5 million in 2024, then tumbled by 35.67% to $6.7 million in 2025, then decreased by 7.51% to $6.2 million in 2026.
• The last three Non-Current Assets figures came in at $6.2 million (Q2 2026), $6.5 million (Q1 2026), and $6.7 million (Q4 2025), per Business Quant data.